Literature DB >> 13472024

Megaloblastic anaemia and vitamin-B12 deficiency after anticonvulsant therapy; report of two cases.

P KIDD, D L MOLLIN.   

Abstract

Entities:  

Keywords:  ANEMIA, HYPERCHROMIC/etiology and pathogenesis; HYDANTOINS/injurious effects; PRIMIDONE/injurious effects; VITAMIN B12 DEFICIENCY/etiology and pathogenesis

Mesh：

Substances：

Year:  1957        PMID： 13472024      PMCID： PMC1962638          DOI： 10.1136/bmj.2.5051.974

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  13 in total

1.  Megaloblastic anaemia of pregnancy and the puerperium.

Authors:  J BADENOCH; S T CALLENDER; J R EVANS; A L TURNBULL; L J WITTS
Journal:  Br Med J       Date:  1955-05-21

2.  Megaloblastic anaemia occurring during primidone therapy.

Authors:  R H GIRDWOOD; J A LENMAN
Journal:  Br Med J       Date:  1956-01-21

3.  Megaloblastic anemia following the use of primidone.

Authors:  M J NEWMAN; D W SUMNER
Journal:  Blood       Date:  1957-02       Impact factor: 22.113

4.  Plasma, tissue and urinary radioactivity after oral administration of 56Co-labelled vitamin B12.

Authors:  C C BOOTH; D L MOLLIN
Journal:  Br J Haematol       Date:  1956-07       Impact factor: 6.998

5.  Megaloblastic anaemia due to barbiturates.

Authors:  Q J HOBSON; D L MOLLIN; J G SELWYN
Journal:  Lancet       Date:  1956-11-24       Impact factor: 79.321

6.  Observations on megaloblastic anaemias after primidone.

Authors:  H FULD; E H MOORHOUSE
Journal:  Br Med J       Date:  1956-05-05

7.  Value of serum iron levels in assessing effect of haematinics in the macrocytic anaemias.

Authors:  C F HAWKINS
Journal:  Br Med J       Date:  1955-02-12

8.  Megaloblastic anaemia due to phenytoin sodium.

Authors:  E G RHIND; S VARADI
Journal:  Lancet       Date:  1954-10-30       Impact factor: 79.321

9.  Vitamin B12 deficiency in the megaloblastic anemias.

Authors:  D L MOLLIN; G I ROSS
Journal:  Proc R Soc Med       Date:  1954-06

10.  Megaloblastic anemia during primidone (mysoline) therapy.

Authors:  W N CHRISTENSON; J E ULTMANN; D M ROSEMAN
Journal:  J Am Med Assoc       Date:  1957-03-16
View more
  6 in total

1.  Megaloblastic anaemia associated with phenobarbital therapy.

Authors:  A L SHERWIN; R H WAIT; B A COOPER
Journal:  Can Med Assoc J       Date:  1960-02-13       Impact factor: 8.262

2.  Folic-acid studies in megaloblastic anaemia due to primidone.

Authors:  I CHANARIN; P C ELMES; D L MOLLIN
Journal:  Br Med J       Date:  1958-07-12

3.  Serum folic-acid and vitamin-B12 levels in anticonvulsant therapy.

Authors:  J S Malpas; G H Spray; L J Witts
Journal:  Br Med J       Date:  1966-04-16

4.  Hyperparathyroidism, osteomalacia and peripheral neuropathy in a patient on anticonvulsant therapy.

Authors:  D McCarthy; N Manning; M Drury
Journal:  Ir J Med Sci       Date:  1977-01       Impact factor: 1.568

5.  The effects of chronic drug administration on hepatic enzyme induction and folate metabolism.

Authors:  D Labadarios; J W Dickerson; D V Parke; E G Lucas; G H Obuwa
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

6.  Reversible absorptive defects in anticonvulsant megaloblastic anaemia.

Authors:  E H Reynolds; J F Hallpike; B M Phillips; D M Matthews
Journal:  J Clin Pathol       Date:  1965-09       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.